Biolot
Biolot is developing a kit that uses a biomarker, F10, to detect myocardial infarction (AMI), and increases the flux of F10 to help doctors make a prognosis of AMI more accurately and at a lower cost.
Team members
Mr Xu Xuezhou* (National University of Singapore)
Miss Wang Hanzhi (Zhejiang University)
Miss Fu Yujing (University of Nottingham Ningbo China)
Miss Tian Tian (PhD student, Dept. of Biomedical Sciences, CityU)
* Person-in-charge
(Info based on the team's application form)
Miss Wang Hanzhi (Zhejiang University)
Miss Fu Yujing (University of Nottingham Ningbo China)
Miss Tian Tian (PhD student, Dept. of Biomedical Sciences, CityU)
* Person-in-charge
(Info based on the team's application form)
Achievement
1. CityU HK Tech 300 Seed Fund (2021)
Email